Heart device users beware. The Homeland Security Department and FDA recently issued warnings about a cybersecurity flaw in one of St. Jude’s medical devices, an implantable heart device. The warning was issued upon discovering that hackers could potentially “take control of a person’s defibrillator or pacemaker” remotely. As if that’s not bad enough, this flaw
For many women, pregnancy is one of those magical times full of excitement. Unfortunately, pregnancy also doles out one particular unpleasant side effect to many moms to be — morning sickness. Morning sickness is one of the more common side effects of pregnancy and impacts an estimated 75% of women. About 1% of women experience
Mylan, a company that came under fire last year for drastically raising their prices of the EpiPen, a lifesaving device used by many across the country, is now back in the news. Despite introducing a generic version of their allergy medication in response to the backlash they received, lawsuits against the company have begun to spring
After willfully failing to follow proper infection control procedures over the course of a year, a dentist who provided care to hundreds of veterans at Wisconsin’s Tomah Veterans Affairs Medical Center has put those he treated at potential risk for developing HIV and Hepatitis B and C. This latest development follows the center’s already tarnished
A recent report released by the FDA indicates over a dozen hospitals nationwide, including three in Massachusetts alone, have been cited for failing to report patient injuries and deaths due to faulty medical devices. The FDA inspected 17 hospitals over a two-year period as part of an improved attempt to ensure problems such as these
As previously reported, Mylan Inc., the pharmaceutical manufacturer of the life-saving EpiPen, misclassified their brand name drug as generic for years, thus deceiving and effectively defrauding governmentally-funded insurance providers Medicare and Medicaid, resulting in millions of dollars in overpayments by taxpayers, all in an effort to save themselves money prior to hiking the price of
United States Senator Richard Blumenthal (D-CT) has written a letter urging the U.S. Department of Justice (DOJ) to reject the proposed $465 million settlement reached between the government and Mylan, Inc. after it was discovered the beleaguered corporation, responsible for increasing the price of the life-saving EpiPen to $600 per 2-pak in August of this
St. Jude Medical, Inc. is a global company that designs and manufactures health management solutions, including heart devices. On October 11, 2016, the company issued a field advisory to physicians, patients and caregivers warning that the company’s Implantable Cardioverter Defibrillator, ICD, and Cardiac Resynchronization Therapy Defibrillator, CRT-D, device batteries may prematurely fail, and a recall
After what was supposed to be a routine gynecological procedure, a California woman realized it would wind up being anything but. Michelle Doig-Collins visited her OB/GYN in April 2016 for a uterine ablation and tubal ligation; the mother of three had been experiencing prolonged bleeding during her menstrual cycle, which left her in a great
Poor Heather Bresch. She just can’t seem to escape the public’s continued outrage over her decision as Mylan’s Big Pharma CEO to increase the price of the life-saving EpiPen in order to line her already custom couture pockets. On Wednesday, September 21, the House Committee on Oversight and Government Reform called Ms. Bresch to testify